Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2025-12-16 @ 10:39 PM
Study NCT ID:
NCT04665245
Status:
None
Last Update Posted:
2025-03-12 00:00:00
First Post:
2020-12-10 00:00:00
Brief Title:
Symptom-Based Markers for COVID-19 Transmission
Sponsor:
University of Iowa
Organization:
University of Iowa
Study Overview
Official Title:
Contact Network Transmission Modeling of Healthcare Associated Infections: Symptom-Based Markers for COVID-19 Transmission
Status:
None
Status Verified Date:
2025-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
One important approach for decreasing COVID-19 transmission in healthcare settings is to prevent healthcare professionals from working while ill. Currently, facilities are asking screening questions and measuring temperatures to help identify symptomatic healthcare professionals and exclude them from providing patient care. Simulations can be used to inform the effectiveness of different screening approaches, but the results of these simulations depend upon the effectiveness of the intervention, e.g., the ability to identify healthcare professionals on their way to work, or to study the impact of healthcare professionals returning to work too early. Thus, simulations must necessarily depend upon realistic disease parameters: for example, it is suspected that a non-trivial proportion of patients with COVID-19 may be asymptomatic or have minimal symptoms, but the relative size of the asymptomatic subpopulation is unknown.
The plan for this study is to develop a method for granular measurement of twice-daily symptoms from healthcare professionals and other research subjects of similar ages. After being diagnosed, the goal is to determine what symptoms participants have and how long they have had them. This will be done using a previously-developed bidirectional texting platform to query participants about symptoms at least twice a day for ten days post diagnosis. Participants will be asked about subjective symptoms, including fevers, chills, cough, shortness of breath, fatigue, gastrointestinal symptoms, etc. They will also take their temperature twice daily during the recovery period, which will help determine the effectiveness of screening based on symptoms and/or thermometer readings.
The plan for this study is to develop a method for granular measurement of twice-daily symptoms from healthcare professionals and other research subjects of similar ages. After being diagnosed, the goal is to determine what symptoms participants have and how long they have had them. This will be done using a previously-developed bidirectional texting platform to query participants about symptoms at least twice a day for ten days post diagnosis. Participants will be asked about subjective symptoms, including fevers, chills, cough, shortness of breath, fatigue, gastrointestinal symptoms, etc. They will also take their temperature twice daily during the recovery period, which will help determine the effectiveness of screening based on symptoms and/or thermometer readings.
Detailed Description:
One important approach for decreasing COVID-19 transmission in healthcare settings is to prevent healthcare professionals from working while ill Currently facilities are asking screening questions and measuring temperatures to help identify symptomatic healthcare professionals and exclude them from providing patient care Simulations can be used to inform the effectiveness of different screening approaches but the results of these simulations depend upon the effectiveness of the intervention eg the ability to identify healthcare professionals on their way to work or to study the impact of healthcare professionals returning to work too early Thus simulations must necessarily depend upon realistic disease parameters for example it is suspected that a non-trivial proportion of patients with COVID-19 may be asymptomatic or have minimal symptoms but the relative size of the asymptomatic subpopulation is unknown
The plan for this study is to develop a method for granular measurement of twice-daily symptoms from healthcare professionals and other research subjects of similar ages After being diagnosed the goal is to determine what symptoms participants have and how long they have had them This will be done using a previously-developed bidirectional texting platform to query participants about symptoms at least twice a day for ten days post diagnosis Participants will be asked about subjective symptoms including fevers chills cough shortness of breath fatigue gastrointestinal symptoms etc They will also take their temperature twice daily during the recovery period which will help determine the effectiveness of screening based on symptoms andor thermometer readings
The plan for this study is to develop a method for granular measurement of twice-daily symptoms from healthcare professionals and other research subjects of similar ages After being diagnosed the goal is to determine what symptoms participants have and how long they have had them This will be done using a previously-developed bidirectional texting platform to query participants about symptoms at least twice a day for ten days post diagnosis Participants will be asked about subjective symptoms including fevers chills cough shortness of breath fatigue gastrointestinal symptoms etc They will also take their temperature twice daily during the recovery period which will help determine the effectiveness of screening based on symptoms andor thermometer readings
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None